PAPP-A and free β-hCG measured prior to 10 weeks is associated with preterm delivery and small-for-gestational-age infants

Prenatal Diagnosis

Volumn 31, Issue 2, 2011, Pages 171-175

  Kirkegaard, Ida ^a   Henriksen, Tine Brink ^a   Tørring, Niels ^a   Uldbjerg, Niels ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Adverse pregnancy outcome; Double test; Free hCG; PAPP A; Preterm delivery; SGA

Indexed keywords

CHORIONIC GONADOTROPIN BETA SUBUNIT; PREGNANCY ASSOCIATED PLASMA PROTEIN A;

ADULT; ALCOHOL CONSUMPTION; ARTICLE; BLOOD LEVEL; BODY HEIGHT; CIGARETTE SMOKING; CONTROLLED STUDY; DENMARK; EDUCATIONAL STATUS; FEMALE; FETUS; FIRST TRIMESTER PREGNANCY; GESTATIONAL AGE; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; MATERNAL AGE; PARITY; PREGNANCY OUTCOME; PREMATURE LABOR; PRENATAL DIAGNOSIS; PRIORITY JOURNAL; SEX DIFFERENCE; SMALL FOR DATE INFANT;

ADULT; BIOLOGICAL MARKERS; CHORIONIC GONADOTROPIN, BETA SUBUNIT, HUMAN; FEMALE; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; INFANT, SMALL FOR GESTATIONAL AGE; PREGNANCY; PREGNANCY OUTCOME; PREGNANCY TRIMESTER, FIRST; PREGNANCY-ASSOCIATED PLASMA PROTEIN-A; PREMATURE BIRTH;

EID: 79251519002     PISSN: 01973851     EISSN: 10970223     Source Type: Journal    
DOI: 10.1002/pd.2671     Document Type: Article

References (19)

1. Bischof P, DuBerg S, Herrmann W, Sizonenko PC. 1981. Pregnancy-associated plasma protein-A (PAPP-A) and hCG in early pregnancy. Br J Obstet Gynaecol 88(10): 973-975.
2. Cole LA, Kohorn EI, Kim GS. 1994. Detecting and monitoring trophoblastic disease. New perspectives on measuring human chorionic gonadotropin levels. J Reprod Med 39(3): 193-200.
3. Dugoff L, Hobbins JC, Malone FD, et al. 2004. First-trimester maternal serum PAPP-A and free-beta subunit human chorionic gonadotropin concentrations and nuchal translucency are associated with obstetric complications: a population-based screening study (the FASTER Trial). Am J Obstet Gynecol 191(4): 1446-1451.
4. Kirkegaard I, Henriksen TB, Uldbjerg N. 2010a. Early fetal growth, PAPP-A and free beta-hCG in relation to the risk of delivering a small-for-gestational age infant. Ultrasound Obstet Gynecol. [Epub ahead of print]. PMID: 20737455.
5. Kirkegaard I, Uldbjerg N, Petersen OB, Tørring N, Henriksen TB. 2010b. PAPP-A, free beta-hCG, and early fetal growth identify two pathways leading to preterm delivery. Prenat Diagn 30(10): 956-963.
6. Kirkegaard I, Petersen OB, Uldbjerg N, Tørring N. 2008. Improved performance of first-trimester combined screening for trisomy 21 with the double test taken before a gestational age of 10 weeks. Prenat Diagn 28(9): 839-844.
7. Kirkegaard I, Petersen OB, Uldbjerg N, Tørring N. 2009. Performance of first-trimester combined screening for trisomy 13 and 18 with the double test taken at a gestational age of 8 + 0 to 13 + 6. Prenat Diagn 29(6): 582-587.
8. Krantz D, Goetzl L, Simpson JL, et al. 2004. Association of extreme first-trimester free human chorionic gonadotropin-beta, pregnancy-associated plasma protein A, and nuchal translucency with intrauterine growth restriction and other adverse pregnancy outcomes. Am J Obstet Gynecol 191(4): 1452-1458.
9. Marsal K, Persson PH, Larsen T, Lilja H, Selbing A, Sultan B. 1996. Intrauterine growth curves based on ultrasonically estimated foetal weights. Acta Paediatr 85(7): 843-848.
10. Nicolaides KH, Spencer K, Avgidou K, Faiola S, Falcon O. 2005. Multicenter study of first-trimester screening for trisomy 21 in 75 821 pregnancies: results and estimation of the potential impact of individual risk-orientated two-stage first-trimester screening. Ultrasound Obstet Gynecol 25(3): 221-226.
11. Ong CY, Liao AW, Spencer K, Munim S, Nicolaides KH. 2000. First trimester maternal serum free beta human chorionic gonadotrophin and pregnancy associated plasma protein A as predictors of pregnancy complications. Br J Obstet Gynaecol 107(10): 1265-1270.
12. Smith GC, Stenhouse EJ, Crossley JA, Aitken DA, Cameron AD, Connor JM. 2002. Early pregnancy levels of pregnancy-associated plasma protein a and the risk of intrauterine growth restriction, premature birth, preeclampsia, and stillbirth. J Clin Endocrinol Metab 87(4): 1762-1767.
13. Spencer CA, Allen VM, Flowerdew G, Dooley K, Dodds L. 2008a. Low levels of maternal serum PAPP-A in early pregnancy and the risk of adverse outcomes. Prenat Diagn 28(11): 1029-1036.
14. Spencer K, Cowans NJ, Avgidou K, Molina F, Nicolaides KH. 2008b. First-trimester biochemical markers of aneuploidy and the prediction of small-for-gestational age fetuses. Ultrasound Obstet Gynecol 31(1): 15-19.
15. Spencer K, Cowans NJ, Molina F, Kagan KO, Nicolaides KH. 2008c. First-trimester ultrasound and biochemical markers of aneuploidy and the prediction of preterm or early preterm delivery. Ultrasound Obstet Gynecol 31(2): 147-152.
16. Spencer K, Cowans NJ, Nicolaides KH. 2008d. Low levels of maternal serum PAPP-A in the first trimester and the risk of pre-eclampsia. Prenat Diagn 28(1): 7-10.
17. Spencer K, Cowans NJ, Avgidou K, Nicolaides KH. 2006. First-trimester ultrasound and biochemical markers of aneuploidy and the prediction of impending fetal death. Ultrasound Obstet Gynecol 28(5): 637-643.
18. Spencer K, Spencer CE, Power M, Dawson C, Nicolaides KH. 2003a. Screening for chromosomal abnormalities in the first trimester using ultrasound and maternal serum biochemistry in a one-stop clinic: a review of three years prospective experience. Br J Obstet Gynaecol 110(3): 281-286.
19. Spencer K, Bindra R, Nicolaides KH. 2003b. Maternal weight correction of maternal serum PAPP-A and free beta-hCG MoM when screening for trisomy 21 in the first trimester of pregnancy. Prenat Diagn 23(10): 851-855.